India's medical technology industry is experiencing significant growth but faces challenges related to heavy reliance on imported medical devices and stringent regulations on raw materials.
Despite these challenges, there is optimism surrounding regulatory reforms and infrastructure development initiatives that aim to strengthen the Med-Tech ecosystem.
Poly Medicure, a leading company in the industry, plans to invest in scaling up existing facilities, pursuing strategic acquisitions, and introducing new products across various therapeutic segments.
The company aims to expand its presence in Europe, the US, and Latin America.
Poly Medicure is committed to diversifying its product portfolio in areas such as interventional cardiology, critical care, and renal care.
The company also aims to strengthen its global presence through partnerships and acquisitions.
The Indian Med-Tech industry has the potential to significantly contribute to the economy and improve healthcare outcomes.
Stakeholders are optimistic about the future and believe that with the right strategies and investments, remarkable milestones can be achieved.